The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Ipsen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Roche Pharma AG
Association of KRT20 and KRT5 with response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer.
 
Florian Roghmann
No Relationships to Disclose
 
Moritz Reike
No Relationships to Disclose
 
Ralph Wirtz
Leadership - STRATIFYER Molecular Pathology
Research Funding - Janssen
 
Maximilian Kriegmair
No Relationships to Disclose
 
Philipp Erben
Research Funding - Janssen
 
Karl Tully
No Relationships to Disclose
 
Veronika Weyerer
Research Funding - Janssen-Cilag (Inst)
 
Markus Eckstein
Honoraria - Astellas Oncology; AstraZeneca; Diaceutics; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag
Research Funding - Janssen-Cilag; Roche; STRATIFYER Molecular Pathology
 
Arndt Hartmann
Honoraria - Ipsen
Consulting or Advisory Role - Ipsen
 
Felix Wezel
No Relationships to Disclose
 
Christian Bolenz
Honoraria - AstraZeneca; AstraZeneca; Janssen-Cilag; Medac; Takeda
Research Funding - ERBE Elektromedizin (Inst)
 
Andrea Tannapfel
Honoraria - Amgen; Falk Pharma; Medupdate; Merck; Pathohistological Testimonials for insurances; Pfizer
 
Joachim Noldus
No Relationships to Disclose
 
Hendrik Juette
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen